日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan

日本一项关于重组抗凝血酶γ治疗先天性抗凝血酶缺乏症患者的上市后安全性和有效性的监测研究

期刊:Thrombosis Journal
影响因子:2.2
doi:10.1186/s12959-026-00844-x
Asakura, Hidesaku; Iwabuchi, Manabu; Fujita, Masaki; Ito, Satoru; Kanda, Yuka; Kuwazawa, Hiroshi
发表日期：2026
文献求助 收藏

Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient

骨髓移植受者腺病毒性膀胱炎诱发的短暂性狼疮抗凝物

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-025-04020-1
Imi, Tatsuya; Asakura, Hidesaku; Sato, Keijiro; Yamada, Shinya; Yoroidaka, Takeshi; Zaimoku, Yoshitaka; Maruyama, Hiroyuki; Hosokawa, Kohei; Yoshida, Akiyo; Takamatsu, Hiroyuki; Ishiyama, Ken; Yamazaki, Hirohito; Kobayashi, Hikaru; Nakao, Shinji; Miyamoto, Toshihiro
微生物学
毒理研究
发表日期：2025
文献求助 收藏

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

我们如何解读血小板减少综合征伴血栓形成？

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms25094956
Yamada, Shinya; Asakura, Hidesaku
血小板
心血管
发表日期：2024
文献求助 收藏

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy

ADAMTS13对血管性血友病因子多聚体的过度切割可能预测移植相关血栓性微血管病的进展。

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2024.102517
Yamada, Shinya; Sakai, Kazuya; Kubo, Masayuki; Okumura, Hirokazu; Asakura, Hidesaku; Miyamoto, Toshihiro; Matsumoto, Masanori
心血管
ADA
发表日期：2024
文献求助 收藏

Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity.

利用血浆触珠蛋白水平和因子 XIII 活性区分免疫介导的血栓性血小板减少性紫癜和脓毒性弥散性血管内凝血

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2023.100076
Yamada Shinya, Asakura Hidesaku, Kubo Masayuki, Sakai Kazuya, Miyamoto Toshihiro, Matsumoto Masanori
其它
血管生成
发表日期：2023
文献求助 收藏

Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study

伊达鲁西珠单抗紧急逆转达比加群抗凝作用：一项日本上市后监测研究的最终结果

期刊:Cardiology and Therapy
影响因子:2.7
doi:10.1007/s40119-023-00333-6
Yasaka, Masahiro; Yokota, Hiroyuki; Suzuki, Michiyasu; Asakura, Hidesaku; Yamane, Teiichi; Ogi, Yukako; Kimoto, Takaaki; Nakayama, Daisuke
发表日期：2023
文献求助 收藏

Identification and Prognostication of End-of-Life State Using a Japanese Guideline-Based Diagnostic Method: A Diagnostic Accuracy Study

基于日本指南的诊断方法在生命末期状态识别与预测中的应用：一项诊断准确性研究

期刊:International Journal of General Medicine
影响因子:2
doi:10.2147/IJGM.S392963
Arahata, Masahisa; Asakura, Hidesaku; Morishita, Eriko; Minami, Shinji; Shimizu, Yukihiro
发表日期：2023
文献求助 收藏

The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study

卡普拉西珠单抗治疗日本免疫介导性血栓性血小板减少性紫癜患者的疗效和安全性：一项开放标签的2/3期研究

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-022-03495-6
Miyakawa, Yoshitaka; Imada, Kazunori; Ichikawa, Satoshi; Uchiyama, Hitoji; Ueda, Yasunori; Yonezawa, Akihito; Fujitani, Shigeki; Ogawa, Yoshiyuki; Matsushita, Tadashi; Asakura, Hidesaku; Nishio, Kenji; Suzuki, Kodai; Hashimoto, Yasuhiro; Murakami, Hidenori; Tahara, Sayaka; Tanaka, Tomoyuki; Matsumoto, Masanori
血小板
心血管
免疫/内分泌
发表日期：2023
文献求助 收藏

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination

COVID-19 和 SARS-CoV-2 疫苗接种中的凝血功能障碍和纤溶病理生理学

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms23063338
Yamada, Shinya; Asakura, Hidesaku
SARS-CoV-2
发表日期：2022
文献求助 收藏

Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors

Xa因子抑制剂治疗患者血浆蛋白S活性的变化

期刊:Journal of Atherosclerosis and Thrombosis
影响因子:2.8
doi:10.5551/jat.62951
Terakami, Takako; Nagaya, Satomi; Hayashi, Kenshi; Furusho, Hiroshi; Fujino, Noboru; Kato, Takeshi; Asakura, Hidesaku; Morishita, Eriko
发表日期：2022
文献求助 收藏